DK1246826T3 - Chlorophyl- og bakteriochlorophylestere, deres fremstilling og farmaceutiske præparater omfattende disse estere - Google Patents

Chlorophyl- og bakteriochlorophylestere, deres fremstilling og farmaceutiske præparater omfattende disse estere

Info

Publication number
DK1246826T3
DK1246826T3 DK00979916T DK00979916T DK1246826T3 DK 1246826 T3 DK1246826 T3 DK 1246826T3 DK 00979916 T DK00979916 T DK 00979916T DK 00979916 T DK00979916 T DK 00979916T DK 1246826 T3 DK1246826 T3 DK 1246826T3
Authority
DK
Denmark
Prior art keywords
sub
sup
esters
coxr
chlorophyll
Prior art date
Application number
DK00979916T
Other languages
Danish (da)
English (en)
Inventor
Avigdor Scherz
Alexander Brandis
Yoram Salomon
Hugo Scheer
Nina Kammhuber
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK1246826T3 publication Critical patent/DK1246826T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/10—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK00979916T 1999-12-01 2000-12-01 Chlorophyl- og bakteriochlorophylestere, deres fremstilling og farmaceutiske præparater omfattende disse estere DK1246826T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13325399A IL133253A0 (en) 1999-12-01 1999-12-01 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
DK1246826T3 true DK1246826T3 (da) 2006-01-02

Family

ID=11073554

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00979916T DK1246826T3 (da) 1999-12-01 2000-12-01 Chlorophyl- og bakteriochlorophylestere, deres fremstilling og farmaceutiske præparater omfattende disse estere

Country Status (19)

Country Link
US (1) US7169753B2 (xx)
EP (1) EP1246826B1 (xx)
JP (1) JP2003515538A (xx)
CN (1) CN1222526C (xx)
AT (1) ATE308545T1 (xx)
AU (1) AU777761B2 (xx)
BR (1) BR0016051A (xx)
CA (1) CA2392989A1 (xx)
DE (1) DE60023748T2 (xx)
DK (1) DK1246826T3 (xx)
ES (1) ES2250214T3 (xx)
HK (1) HK1056557A1 (xx)
HU (1) HU224553B1 (xx)
IL (1) IL133253A0 (xx)
MX (1) MXPA02005455A (xx)
NO (1) NO323208B1 (xx)
PL (1) PL356391A1 (xx)
RU (1) RU2250905C2 (xx)
WO (1) WO2001040232A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US20060212025A1 (en) 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
EP1318807A4 (en) * 2000-08-11 2008-02-20 Ceramoptec Gmbh LIGHT-SENSITIVE OINTMENT
BR0304716A (pt) 2002-05-08 2004-07-13 Yeda Res & Dev Método para formação de imagens de mri-bold on line, sensibilizada
IL152900A0 (en) 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
ES2572976T3 (es) 2003-07-31 2016-06-03 Gentlewaves Llc Sistema y método para el tratamiento fotodinámico de la piel
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
EP2322173B1 (en) * 2004-06-07 2016-08-10 Yeda Research And Development Co., Ltd. Cationic bacteriochlorophyll derivatives and uses thereof
AU2005251395A1 (en) 2004-06-09 2005-12-22 Qlt Inc. Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
FR2924021B1 (fr) * 2007-11-27 2010-08-13 Du Vernet Michele Eymard Composition pour le traitement de la peau par therapie photodynamique
CN101925382A (zh) * 2008-01-28 2010-12-22 耶达研究及发展有限公司 内窥镜成像光动力学治疗系统及其使用方法
MX2010009530A (es) 2008-02-27 2010-11-30 Yeda Res & Dev Conjugados de rgd-(bacterio) clorofila para terapia fotodinámica y formación de imágenes de tumores necróticos.
AU2012205410A1 (en) 2011-01-13 2013-08-01 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
KR101962991B1 (ko) * 2011-08-23 2019-03-27 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 안질환 및 질병 치료용 박테리오 클로로필 광민감제
BR112015000383A2 (pt) 2012-07-11 2017-06-27 Dermira Inc composição farmacêutica, e, métodos para preparação de uma composição farmacêutica, para reduzir a taxa de excreção de sebo das glândulas sebáceas na pele de um indivíduo e para tratamento da acne
CA2917545C (en) 2013-07-12 2022-01-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery
RU2021110230A (ru) * 2016-04-10 2021-05-26 Йеда Рисерч Энд Дивелопмент Ко. Лтд. Комбинированные способы терапии для лечения злокачественной опухоли
CN108341827A (zh) * 2018-02-02 2018-07-31 浙江海正药业股份有限公司 一种制备脱镁细菌叶绿素a及脱镁细菌叶绿素a酯的方法
CN108191877A (zh) * 2018-02-05 2018-06-22 云南瑞宝生物科技股份有限公司 一种从蚕沙中提取和纯化叶绿素的方法
CN111171030B (zh) * 2018-11-12 2022-11-22 浙江海正药业股份有限公司 细菌叶绿素衍生物及其制备方法
CN111848656B (zh) * 2020-06-24 2023-03-14 天津大学 离子修饰的原卟啉镓化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171741A (en) 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE4121876A1 (de) * 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
DE4121867A1 (de) 1991-07-02 1993-01-07 Leifeld & Lemke Maschf Vorrichtung zur pruefung der dichtigkeit von mit deckeln luftdicht verschlossenen bechern
IL102645A (en) * 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
CA2392989A1 (en) 2001-06-07
DE60023748D1 (de) 2005-12-08
HK1056557A1 (en) 2004-02-20
HUP0204167A2 (hu) 2003-03-28
AU1729201A (en) 2001-06-12
CN1222526C (zh) 2005-10-12
CN1425015A (zh) 2003-06-18
EP1246826A1 (en) 2002-10-09
MXPA02005455A (es) 2002-11-29
EP1246826B1 (en) 2005-11-02
NO323208B1 (no) 2007-01-22
AU777761B2 (en) 2004-10-28
NO20022599D0 (no) 2002-05-31
PL356391A1 (en) 2004-06-28
NO20022599L (no) 2002-07-11
JP2003515538A (ja) 2003-05-07
US20030148926A1 (en) 2003-08-07
IL133253A0 (en) 2001-04-30
HU224553B1 (hu) 2005-10-28
ATE308545T1 (de) 2005-11-15
WO2001040232A9 (en) 2002-09-12
WO2001040232A1 (en) 2001-06-07
BR0016051A (pt) 2002-07-23
HUP0204167A3 (en) 2004-08-30
DE60023748T2 (de) 2006-08-03
US7169753B2 (en) 2007-01-30
ES2250214T3 (es) 2006-04-16
RU2250905C2 (ru) 2005-04-27

Similar Documents

Publication Publication Date Title
DK1246826T3 (da) Chlorophyl- og bakteriochlorophylestere, deres fremstilling og farmaceutiske præparater omfattende disse estere
WO2000040269A3 (en) Pharmaceutical compositions for treatment of diseased tissues
GEP20022804B (en) Erythropoietin Derivatives
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
CY1106152T1 (el) Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids
FI955552A0 (fi) Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa
FI954541A0 (fi) Keratinosyyttikasvutekijän terapeuttisia käyttöjä
DE69822496D1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
RU94046426A (ru) Фармацевтические композиции, способы лечения лейкоза, способ повышения уровней стволовых клеток, антагонист с - kit - лиганда, антисмысловая нуклеиновая кислота, способ лечения меланомы, способ усиления трансфекции, способ переноса гена, способ увеличения уровней периферической крови, способ повышения уровней тромбоцитов, способы модификации биологической функции, способ лечения анемии, способ улучшения приживления костного мозга, способ ускорения восстановления костного мозга, способ лечения лейкопении
IL161177A0 (en) Pharmaceutical preparation useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
AU6721998A (en) Therapeutic use of the smr1 protein and active derivatives thereof
WO1994006449A3 (en) Morphogen-induced liver regeneration
PT941110E (pt) Utilizacao do factor 2 de crescimento dos ceratinocitos
ATE258442T1 (de) Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
RU2136695C1 (ru) Сывороточный гликопротеин, обладающий биологической активностью в сверхмалых дозах
AU1318797A (en) Peptides and uses thereof for therapy of celiac diseases
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
RU94039629A (ru) Стимулятор роста костномозговых клеток человека
FI972121A0 (fi) Sammansaettningar foer reciprok oekning av immunosupperssanters och interferoners farmaceutiska aktiviteter
Wang et al. Reducing systemic toxicity in local tumor gene therapy using an alginate solution
DE60028682D1 (de) Wachstumhormone Inhibitoren Enthaltende pharmazeutische Zubereitungen oder ihre biologisch aktive Fragmente zur Behandlung von uterinen Myomas
MX9708615A (es) Terapia de genes animales.
UA91488C2 (ru) Новый класс физиологически активных гликопротеинов